LARIMAR THERAPEUTICS, INC. Operating Leases, Future Minimum Payments Due, Next Twelve Months
LARIMAR THERAPEUTICS, INC. (LRMR) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $464.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-05.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2020-03-05
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $464.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $479.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $300.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $432.00K.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2018-12-31 | $464.00K 10-K · filed 2020-03-05 |
| 2017-12-31 | $479.00K 10-K · filed 2018-03-09 |
| 2016-12-31 | $300.00K 10-K · filed 2017-03-10 |
| 2015-12-31 | $432.00K 10-K · filed 2016-03-15 |
| 2014-12-31 | $229.00K 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |